- Home
- Research & Innovation
- News
- College Team
- Programmes
- Hospital Partners
- Community Partners
- Jennings Gallery
- Graduate Studies
- Programmes for International (Non-EU) Students
- Interprofessional Learning (IPL)
- ASSERT
- Dr Ashleigh Byrne-O’Brien Memorial Fund
- iEd Hub
- Inaugural Professorial Lecture Series
- Learning, Teaching & Curriculum
- Philanthropic Lectures
- UCC Academic Health Sciences
- Continuing Professional Development
News
Announcing our second CoMH Philanthropic Lecture

"Future Cancer Medicine: Bridging the Academic/Clinical Interface" with Prof Jack Gleeson
The College is very grateful for the support our academics and researchers receive through corporate philanthropy, bringing together academic and clinical researchers, to better address knowledge gaps and impact the lives of patients.
The College of Medicine & Health, in conjunction with Alumni & Development, is pleased to announce that we will host our second CoMH Philanthropic Lecture on 10th May 2024.
In conjunction with Alumni & Development, we invite you to attend The UPMC Lecture with Professor Jack Gleeson, Professor (Scale II) of Oncology, Consultant Medical Oncologist.
Date Friday 10th May, 1.15pm - 2.15pm (Irish Local Time) |
Venue Room G10 BHSC - Brookfield Health Sciences Complex UCC Refreshments served afterwards in the Jennings Gallery Link for hybrid lecture A MS Teams meeting link will be made available here in advance of the lecture. If you register, the link will be emailed to you. If you would like to attend the lecture Please complete this MS Form by noon on Wednesday 8th May to register your interest in attending in person or online. |
Lecture Title "Future Cancer Medicine:Bridging the Academic/Clinical Interface". "Cancer is daunting in the breadth and scope of its diversity, spanning genetics, cell and tissue biology, pathology, individual patient factors and response to therapy. Our aim is to more fully understand the mechanisms of cancer development and malignant progression, and to apply that knowledge to cancer medicine. UCC Futures - Future Medicines is focused on creating step-change advancements in earlier detection, faster prognosis and targeted treatments to reduce the global health burden and improve quality-of-life for patients with many conditions, including cancer. Developing novel, more effective and more personalised cancer medicines that increase survival, with improved quality of life and no/minimal toxicity from treatment is our goal. Clinical researchers who bridge the academic/clinical interface and have time dedicated to both seeing patients and academic research have a crucial role in the future of cancer medicine". Prof Gleeson
|
For more information about Prof Jack Gleeson Please click here. |
For more on this story contact:
Caroline Seacy | Marketing and Events Manager | caroline.seacy@ucc.ie